Document is current
Any future updates will be listed below
-
Authors
Wen, Xuerong
Lawal, Oluwadolapo D. https://orcid.org/0000-0003-4466-6675
Belviso, Nicholas
Matson, Kelly L.
Wang, Shuang
Quilliam, Brian J.
Meador, Kimford J.
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R15HD097588)
- License Information
-
More Information
Article History
Accepted: 16 May 2021
First Online: 7 June 2021
Declarations
:
: All authors were responsible for critical revision of the manuscript for intellectual content. All authors read and approved the final version. Wen, Lawal and Meador conceptualized and designed this study, and drafted the initial version of the manuscript. Wen, Meador, Lawal and Belviso contributed to data preparation, statistical analyses, and interpretation. Wang contributed to statistical analyses and interpretation. Matson and Quilliam provided clinical and technical support, and contribution to interpretation of study findings.
: Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R15HD097588. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Principal Investigator: Wen X. The funding source had no role in the design or conduct of the study; collection, management, analysis, or the interpretation of the data preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
: Dr Meador has received research support from the National Institutes of Health and Sunovion Pharmaceuticals, and travel support from Eisai. The Epilepsy Study Consortium pays Dr Meador’s university for his research consultant time related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, and UCB Pharma. The other authors have no conflicts of interests to declare.
: This study uses deidentified data, hence was considered exempt by the University of Rhode Island Institutional Review Board.
: Not applicable.
: Not applicable.
: A data use agreement exists between The University of Rhode Island College of Pharmacy and Optum. The Optum Clinformatics Data Mart database cannot be shared by authors with parties external to this agreement.
: Not applicable.
